132 related articles for article (PubMed ID: 19934833)
1. Comment on "Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity".
Er H
Retina; 2009 Oct; 29(9):1380; author reply 1379-80. PubMed ID: 19934833
[No Abstract] [Full Text] [Related]
2. Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity.
Lalwani GA; Berrocal AM; Murray TG; Buch M; Cardone S; Hess D; Johnson RA; Puliafito CA
Retina; 2008 Mar; 28(3 Suppl):S13-8. PubMed ID: 18317338
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab for retinopathy of prematurity.
Reynolds JD
N Engl J Med; 2011 Feb; 364(7):677-8. PubMed ID: 21323546
[No Abstract] [Full Text] [Related]
4. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin).
Dorta P; Kychenthal A
Retina; 2010 Apr; 30(4 Suppl):S24-31. PubMed ID: 20224475
[TBL] [Abstract][Full Text] [Related]
5. Is Avastin the right choice of treatment for retinopathy of prematurity?
Käll A
Acta Paediatr; 2012 Aug; 101(8):796-8. PubMed ID: 22788788
[No Abstract] [Full Text] [Related]
6. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.
O'Keefe M
Ir Med J; 2011; 104(7):197. PubMed ID: 21957683
[No Abstract] [Full Text] [Related]
7. Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity.
Erol N; Gürsoy H; Sahin A; Basmak H
J Pediatr Ophthalmol Strabismus; 2010 Aug; 47 Online():e1-4. PubMed ID: 21158371
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab for retinopathy of prematurity.
Gilbert CE; Zin A; Darlow B
N Engl J Med; 2011 Jun; 364(24):2359-60; author reply 2361-2. PubMed ID: 21675898
[No Abstract] [Full Text] [Related]
9. Avastin as monotherapy for retinopathy of prematurity.
Mintz-Hittner HA
J AAPOS; 2010 Feb; 14(1):2-3. PubMed ID: 20227612
[No Abstract] [Full Text] [Related]
10. Bevacizumab for retinopathy of prematurity.
Lim LS; Mitchell P; Wong TY
N Engl J Med; 2011 Jun; 364(24):2360; author reply 2361-2. PubMed ID: 21675897
[No Abstract] [Full Text] [Related]
11. Paradoxical vascular-fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity.
Zepeda-Romero LC; Liera-Garcia JA; Gutiérrez-Padilla JA; Valtierra-Santiago CI; Avila-Gómez CD
Eye (Lond); 2010 May; 24(5):931-3. PubMed ID: 19557020
[No Abstract] [Full Text] [Related]
12. Retinal detachment despite aggressive management of aggressive posterior retinopathy of prematurity.
Suk KK; Berrocal AM; Murray TG; Rich R; Major JC; Hess D; Johnson RA
J Pediatr Ophthalmol Strabismus; 2010 Dec; 47 Online():e1-4. PubMed ID: 21175113
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab for retinopathy of prematurity.
Gole GA; Camuglia JE; Ells AL
N Engl J Med; 2011 Jun; 364(24):2360-1; author reply 2362. PubMed ID: 21675896
[No Abstract] [Full Text] [Related]
14. Bevacizumab (Avastin) for retinopathy of prematurity: wrong dose, wrong drug, or both?
Avery RL
J AAPOS; 2012 Feb; 16(1):2-4. PubMed ID: 22237669
[No Abstract] [Full Text] [Related]
15. Intravitreal bevacizumab for retinopathy of prematurity as first line or rescue therapy with focal laser treatment. A case series.
Dani C; Frosini S; Fortunato P; Bertini G; Pratesi S; Pollazzi L; Caputo R; La Torre A
J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2194-7. PubMed ID: 22506618
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab (avastin) for the treatment of retinopathy of prematurity.
Beaulieu MJ
Neonatal Netw; 2012; 31(4):242-7. PubMed ID: 22763251
[No Abstract] [Full Text] [Related]
17. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
Nowroozzadeh MH
Retina; 2009 Apr; 29(4):564-5; author reply 565-8. PubMed ID: 19262428
[No Abstract] [Full Text] [Related]
18. A new, theoretically safer method of intravitreal injection of bevacizumab in progressive retinopathy of prematurity using scleral trans-illumination.
Patel CK; Walker NJ; Kam JK
Br J Ophthalmol; 2010 Aug; 94(8):1107-9. PubMed ID: 20558426
[No Abstract] [Full Text] [Related]
19. Our experience after 1765 intravitreal injections of bevacizumab: the importance of being part of a developing story.
Quiroz-Mercado H; Ustariz-González O; Martinez-Castellanos MA; Covarrubias P; Dominguez F; Sanchez-Huerta V
Semin Ophthalmol; 2007; 22(2):109-25. PubMed ID: 17564934
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab for the treatment of retinopathy of prematurity: a case report.
Flavahan PW; Lavy TE; Wykes W
Scott Med J; 2013 Aug; 58(3):130-2. PubMed ID: 23960050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
